441 related articles for article (PubMed ID: 31165788)
21. Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.
Fiorotto R; Amenduni M; Mariotti V; Fabris L; Spirli C; Strazzabosco M
Hepatology; 2018 Mar; 67(3):972-988. PubMed ID: 28836688
[TBL] [Abstract][Full Text] [Related]
22. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases.
Cadamuro M; Girardi N; Gores GJ; Strazzabosco M; Fabris L
Front Med (Lausanne); 2020; 7():115. PubMed ID: 32373615
[TBL] [Abstract][Full Text] [Related]
23. Bile Acids and Biliary Fibrosis.
Aseem SO; Hylemon PB; Zhou H
Cells; 2023 Mar; 12(5):. PubMed ID: 36899928
[TBL] [Abstract][Full Text] [Related]
24. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.
Fiorotto R; Villani A; Kourtidis A; Scirpo R; Amenduni M; Geibel PJ; Cadamuro M; Spirli C; Anastasiadis PZ; Strazzabosco M
Hepatology; 2016 Dec; 64(6):2118-2134. PubMed ID: 27629435
[TBL] [Abstract][Full Text] [Related]
25. Fibrocystic liver disease: novel concepts and translational perspectives.
Lasagni A; Cadamuro M; Morana G; Fabris L; Strazzabosco M
Transl Gastroenterol Hepatol; 2021; 6():26. PubMed ID: 33824930
[TBL] [Abstract][Full Text] [Related]
26. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
Pinto C; Giordano DM; Maroni L; Marzioni M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
[TBL] [Abstract][Full Text] [Related]
27. MRI for evaluating congenital bile duct abnormalities.
Krausé D; Cercueil JP; Dranssart M; Cognet F; Piard F; Hillon P
J Comput Assist Tomogr; 2002; 26(4):541-52. PubMed ID: 12218818
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1
Fabris L; Milani C; Fiorotto R; Mariotti V; Kaffe E; Seller B; Sonzogni A; Strazzabosco M; Cadamuro M
FASEB J; 2022 Jun; 36(6):e22364. PubMed ID: 35593740
[TBL] [Abstract][Full Text] [Related]
29. Hepatobiliary complications of cystic fibrosis.
Feranchak AP
Curr Gastroenterol Rep; 2004 Jun; 6(3):231-9. PubMed ID: 15128491
[TBL] [Abstract][Full Text] [Related]
30. Hepatobiliary disease in patients with cystic fibrosis.
Moyer K; Balistreri W
Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
[TBL] [Abstract][Full Text] [Related]
31. Cholangiocytes derived from induced pluripotent stem cells for disease modeling.
Ghanekar A; Kamath BM
Curr Opin Gastroenterol; 2016 May; 32(3):210-5. PubMed ID: 27054776
[TBL] [Abstract][Full Text] [Related]
32. [Fibropolycystic diseases of the liver and bile ducts--a case report and review of the literature].
Stümpflen A; Kyrle PA; Amann G; Mühlbacher F; Pötzi R; Walter R
Wien Klin Wochenschr; 1988 Dec; 100(23):765-9. PubMed ID: 3062909
[TBL] [Abstract][Full Text] [Related]
33. Peribiliary glands: development, dysfunction, related conditions and imaging findings.
Matsubara T; Kozaka K; Matsui O; Nakanuma Y; Uesaka K; Inoue D; Yoneda N; Yoshida K; Kitao A; Yokka A; Koda W; Gabata T; Kobayashi S
Abdom Radiol (NY); 2020 Feb; 45(2):416-436. PubMed ID: 31707436
[TBL] [Abstract][Full Text] [Related]
34. Cholangiocyte pathobiology.
Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
[TBL] [Abstract][Full Text] [Related]
35. [Inflammatory and neoplastic cholangiopathies.].
Alvaro D; Bragazzi MC; Ridola L
Recenti Prog Med; 2018 Dec; 109(12):595-599. PubMed ID: 30667389
[TBL] [Abstract][Full Text] [Related]
36. Caroli's disease in congenital hepatic fibrosis and infantile polycystic disease.
Nakanuma Y; Terada T; Ohta G; Kurachi M; Matsubara F
Liver; 1982 Dec; 2(4):346-54. PubMed ID: 7167037
[TBL] [Abstract][Full Text] [Related]
37. Repopulating the biliary tree from the peribiliary glands.
de Jong IEM; van Leeuwen OB; Lisman T; Gouw ASH; Porte RJ
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1524-1531. PubMed ID: 28778591
[TBL] [Abstract][Full Text] [Related]
38. Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.
Luo Z; Jegga AG; Bezerra JA
Hepatology; 2018 Feb; 67(2):676-689. PubMed ID: 28865156
[TBL] [Abstract][Full Text] [Related]
39. [Cystic liver diseases. Genetics and cell biology].
Housset C
Gastroenterol Clin Biol; 2005; 29(8-9):861-9. PubMed ID: 16294159
[TBL] [Abstract][Full Text] [Related]
40. Animal models for cystic fibrosis liver disease (CFLD).
Fiorotto R; Amenduni M; Mariotti V; Cadamuro M; Fabris L; Spirli C; Strazzabosco M
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):965-969. PubMed ID: 30071276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
